When exposed to proteotoxic environmental conditions, mammalian cells activate the cytosolic stress response in order to restore protein homeostasis. A key feature of this response is the heat shock transcription factor 1 (HSF1)-dependent expression of molecular chaperones. Here, we describe the results of an RNA interference screen in HeLa cells to identify modulators of stress response induction and attenuation. The modulator proteins are localized in multiple cellular compartments, with chromatin modifiers and nuclear protein quality control playing a central regulatory role. We find that the acetyltransferase, EP300, controls the cellular level of activatable HSF1. This involves acetylation of HSF1 at multiple lysines not required for function and results in stabilization of HSF1 against proteasomal turnover. Acetylation of functionally critical lysines during stress serves to fine-tune HSF1 activation. Finally, the nuclear proteasome system functions in attenuating the stress response by degrading activated HSF1 in a manner linked with the clearance of misfolded proteins.
INTRODUCTION
The cytosolic stress response, generally known as the heat shock response (HSR), is one of the primary defense mechanisms activated by cells to maintain protein homeostasis (proteostasis) when exposed to proteotoxic conditions (Anckar and Sistonen, 2011; Gidalevitz et al., 2011; Neef et al., 2011) . The eukaryotic HSR is highly conserved and results in the increased production of heat shock proteins (HSPs)-mainly molecular chaperones and proteases that prevent the aggregation of misfolded proteins and mediate their refolding or degradation (Frydman, 2001 ; Hartl et al., 2011; Richter et al., 2010) . Activation of the HSR can be autonomously triggered by protein damage occurring in isolated cells due to adverse external conditions, such as exposure to elevated temperature or protein denaturing agents, or when cells express proteins that are unable to fold due to mutation or incorporation of amino acid analogs. In metazoans, stress response pathways, including the HSR, are also subject to cell-non-autonomous and tissue selective control, apparently by mechanisms of endocrine communication between tissues and organs (Durieux et al., 2011; Guisbert et al., 2013; Prahlad et al., 2008; van Oosten-Hawle et al., 2013) .
Induction of the HSR is mediated by heat shock transcription factors (HSFs). Four distinct but related HSFs are known in vertebrates (HSF1 to HSF4) (Anckar and Sistonen, 2011) , with HSF1 being the master regulator. Besides controlling the expression of HSPs, HSF1 also regulates transcriptional programs supporting cell survival and tumorigenesis (Mendillo et al., 2012; Santagata et al., 2013) . Human HSF1 is an $57 kDa protein consisting of a N-terminal DNA-binding domain, a bipartite heptad repeat oligomerization domain, a regulatory domain, and a C-terminal transactivation domain (Anckar and Sistonen, 2011; Neef et al., 2011) . Stress-dependent transcriptional regulation by HSF1 is a multistep process that is only partially understood. Inactive HSF1 monomers are predominantly located in the nucleus due to a potent bipartite nuclear localization signal, but HSF1 shuttling between the nucleus and cytosol has been reported. Thermal stress inhibits HSF1 export, leading to further nuclear accumulation (Anckar and Sistonen, 2011; Mercier et al., 1999) . Monomeric HSF1 is stabilized by binding to chaperones, including Hsp70, Hsp90, and their cofactors. Activation requires dissociation from these chaperones, generally due to displacement by misfolded proteins accumulating under stress (Morimoto, 2002; Shi et al., 1998; Zou et al., 1998) . Free HSF1 then trimerizes and acquires competence for binding to heat shock elements in the promoter regions of target genes (Anckar and Sistonen, 2011; Pelham, 1982) . Complex posttranslational modifications are additionally involved in rendering HSF1 transactivation competent by mechanisms that are not well understood. Oligomerization is accompanied by phosphorylation of multiple serine residues in the regulatory domain (Batista-Nascimento et al., 2011; Guettouche et al., 2005) . A phosphorylation-dependent sumoylation step is thought to be involved in HSF1 repression (Hietakangas et al., 2003) . Furthermore, acetylation at lysine 80 in the DNA-binding domain was shown to reduce the dwell time of HSF1 on DNA, accelerating HSR attenuation (Westerheide et al., 2009) .
Protein misfolding and aggregation are linked to numerous pathological conditions, including neurodegeneration, type II diabetes, and heart disease. The manifestation of many of these diseases may be related to an age-dependent decline of cellular proteostasis capacity (Ben-Zvi et al., 2009; Gupta et al., 2011; Powers et al., 2009) . Thus, boosting proteostasis by pharmacologically activating the HSR may serve to mitigate these degenerative conditions (Calamini et al., 2012; Neef et al., 2011; Powers et al., 2009) . In contrast, tumor cells are generally more dependent on chaperone capacity than untransformed cells (Dai et al., 2007) , due to the accumulation of destabilizing mutations in key signaling proteins. Hence, inhibition of the HSR is considered beneficial in cancer treatment. However, relatively little is known about the cellular pathways that regulate the HSR, and potential targets for its activation or inhibition remain to be identified.
In order to elucidate the mechanism underlying the regulation of the HSR, we have conducted a genome-scale RNAi screen in HeLa cells. We find that the nuclear machineries involved in chromatin modification and protein quality control have a central role in regulating the induction and attenuation of the stress response. In the absence of stress, the acetyltransferase, EP300, controls the pool of activatable HSF1. This involves stabilization of HSF1 by acetylation at multiple lysines. Additional acetylation at functionally critical lysines during heat stress dampens the HSR. As shown by proteomic analysis, the proteasome system has an essential role in restoring the nuclear proteome after stress. This function is coupled with attenuation of the HSR through the degradation of HSF1.
RESULTS

RNAi Screen for Modulators of the Heat Shock Response
To conduct a genome-scale RNAi screen for modulators of the HSR, we generated a HeLa reporter cell line, iFluc-Rluc, expressing stress-inducible firefly luciferase (Fluc) under the human HSPA1A (hsp70.1) promoter and the unrelated luciferase of Renilla reniformis (Rluc) under the constitutive cytomegalovirus (CMV) promoter. HSF1 binds to the hsp70.1 promoter upon stress and induces Fluc expression. The ratio of Fluc to Rluc luminescence activities serves as a measure of HSR induction ( Figure 1A ). Fluc and Rluc are thermolabile enzymes (Gupta et al., 2011) and are deactivated by heat treatment but regain most of their specific activity within $10 min during recovery (Figure S1A available online). Downregulation of positive or negative modulators of the HSR by RNAi would reduce or enhance the expression of Fluc, respectively.
Heat stress (HS) at 43 C for 2 hr induced Fluc expression, and the Fluc:Rluc activity ratio measured upon recovery at 37 C increased up to 50-fold ( Figures 1B and S1B) ; longer HS exposure resulted in partial attenuation of the HSR and reduced cell viability ( Figure 1B) . To test the dependence of Fluc expression on HSF1, iFluc-Rluc cells were transfected with an endoribonuclease-prepared short interfering RNA (esiRNA) (Kittler et al., 2005) targeting HSF1 or with a control esiRNA against enhanced green fluorescent protein (EGFP). 68 hr after transfection, cells Figure S1 .
were either exposed to HS, followed by recovery at 37 C, or maintained at 37 C ( Figure 1C ). EGFP esiRNA had no effect on the induction of the stress response, as judged by the Fluc:Rluc activity ratio ( Figure 1C ). The level of Fluc and HSPA1A mRNA, measured immediately after HS, was increased, whereas Rluc mRNA remained constant during HS and recovery (Figures 1D and S1B) . In contrast, the Fluc:Rluc activity ratio upon HS was reduced >4-fold upon silencing of HSF1 ( Figure 1C) , which is consistent with the loss of induction of Fluc and endogenous HSPA1A mRNA during HS ( Figure 1D) .
The primary RNAi screen was performed by transfecting iFlucRluc cells with individual esiRNAs targeting more than 15,000 human genes ( Figure S1C and Extended Experimental Procedures). A low stringency protocol was followed to minimize false-negative results (Z score deviation -2.5/+2 from average for positive and negative modulators, respectively) ( Figure S1D ). Using these criteria, esiRNAs targeting the transcripts of 705 genes caused a significant reduction in Fluc:Rluc activity ratio upon HS, whereas esiRNAs targeting an additional 287 transcripts enhanced the response ( Figure S1C and Tables S1A and S1B), suggesting a role for these genes as positive or negative modulators of the HSR, respectively. To identify the strongest HSR modulators, we repeated the screen for this set of candidates in triplicate using more stringent criteria (Z score deviation from average of ±3 in all 3 independent repeats). We confirmed 116 positive and 54 negative modulators (Figures S1C and S1E and Table S1C). A second round of validation was then performed with esiRNAs targeting independent regions of these transcripts, which identified a final set of 55 positive and 14 negative modulators (Figures S1C and S1F and Tables S1D and S1E).
Overview of HSR Modulators and Functional Validation
The screen revealed that regulation of the HSR relies on the integration of signals generated in several cellular processes and cell compartments (Figure 2A and Tables S1D and S1E). Approximately 40% of the modulator proteins (24 positive and 2 negative) have their primary location in the nucleus. 17 modulators ($25%) are cytoplasmic (or cytoplasmic and nuclear), and 13 modulators are localized in organelles (mitochondria, endoplasmic reticulum, and lysosomes) or the plasma membrane. Another 13 modulators are poorly characterized and include proteins with predicted nuclear localization signals or transmembrane segments (Figure 2A and Tables S1D and S1E).
A central function of the HSR is to prevent protein aggregation under cell stress. To verify that the positive HSR modulators influence this process, we downregulated a representative set of modulators in HEK293T cells stably expressing the proteostasis sensor protein FlucDM-GFP (Gupta et al., 2011) . This reporter carries two destabilizing mutations in Fluc, which render the protein aggregation sensitive. Silencing of the positive HSR modulators strongly increased visible FlucDM-GFP inclusions upon HS compared to cells transfected with control esiRNA (Rluc or OLFML3) (Figures 2B and S2A) . No significant increase in aggregation was observed when the negative HSR modulator, DAP3, was downregulated ( Figure 2B ). Downregulation of proteasome subunits did not suppress inclusion formation ( Figures 2B and S2A ), presumably because proteasome inhibition prevents the clearance of misfolded FlucDM-GFP (Park et al., 2013) .
The nuclear HSR modulators include several subunits of histone acetyltransferase complexes, such as EP300, CREBbinding protein (CREBBP), and SRCAP, as well as four histone methyltransferases (Figure 2A ), underscoring the importance of chromatin reorganization in heat shock gene transcription (Petesch and Lis, 2008 FlucDM-GFP inclusions was quantified. OLFML3 downregulation had no effect on Fluc:Rluc activity ratio in the primary screen (Table S1A ) and served as a negative control. SDs represent results from at least three different fields of view ($200 cells per view). See also Figure S2 and Table S1 .
interfered with the induction of endogenous HSPA1A mRNA during HS ( Figure S2B ). The identification of core components of the mRNA splicing machinery as positive HSR modulators was surprising, as splicing is generally inhibited during HS (Biamonti and Caceres, 2009) . We found that downregulation of SF3B1, SMU1, and SNRPF lowered the mRNA and protein level of HSF1 ( Figure S2C ), explaining the reduced activation of the HSF1 reporter. The RNA transport proteins identified by the screen are likely important for exporting newly synthesized mRNAs to the cytoplasm under stress conditions. Comparatively few positive modulators with diverse functions were identified in the cytoplasm (Table S1D) . Their association with the HSR remains to be investigated. The identification of several multipass membrane proteins as positive HSR modulators is intriguing. These proteins include putative cell surface receptors (SSTR1; TM7SF3; PAQR5) with seven transmembrane helices that may function as G-proteincoupled receptors and could play a role in stress sensing or communicating stress status between cells. The modulators in the cell membrane also include the KCND1 potassium channel, which is consistent with a proposed role of potassium and calcium channels in the HSR in mammalian and plant cells (Finka et al., 2012; Saad and Hahn, 1992) .
The absence of kinases and major chaperone components among the identified HSR modulators is notable. Phosphorylation of HSF1 is considered critical for activation, but multiple kinases have been reported to be involved (Anckar and Sistonen, 2011; Batista-Nascimento et al., 2011; Guettouche et al., 2005) , suggesting functional redundancy. Similarly, redundancy among the chaperones participating in HSF1 activation may have prevented their identification. Although subunits of the cytosolic chaperonin TRiC/CCT and the Hsp70-Hsp90 organizing protein Hop (STIP1) were identified as positive modulators, this may be explained by the chaperone requirement of the Fluc reporter for folding. Indeed, downregulation of these components did not prevent the induction of HSPA1A mRNA upon HS (data not shown).
Most of the negative HSR modulators are components of the ubiquitin-proteasome system (UPS), including six subunits of the 20S proteasome core complex, one subunit of the 19S regulatory particle (PSMD11), and two other UPS components, RBX1 and NPLOC4 ( Figure 2A ). The proteasome is localized to the cytoplasm and nucleus (Russell et al., 1999) . As shown below, silencing of proteasomal subunits delayed the attenuation of the HSR. Table S2A ). 31 of the modulators in this network are either localized exclusively in the nucleus (24 proteins) or shuttle between the nucleus and cytoplasm (7 proteins). The number of proteins connected (449) is significantly greater than observed on average with randomly chosen proteins (80; p < 2.2 3 10 À16 ). The chromatin modifiers form a central element of the HSR network, with the EP300/CREBBP histone acetyltransferase complex interacting directly with SRCAP (Snf2-related CREBBP activator protein) and via other proteins with HSF1 ( Figure 3 and Table S2A ). The connecting proteins between EP300/CREBBP and HSF1 are mainly histone deacetylases and transcriptional coactivators. They include TAF12 and TAF5L, subunits of the PCAF histone acetyltransferase complex, and the histone methyltransferases RBBP5 (retinoblastoma-binding protein) and DPY30, which cooperate in methylating lysine 4 on histone H3, resulting in transcriptional activation. The RBBP5/DPY30 complex connects via other proteins to EP300/CREBBP and to the E3 ubiquitin protein ligase RBX1, a negative HSR modulator. RBX1 is also connected to EP300/CREBBP and to the proteasome. The HSR network includes 63 proteins (Figure 3 , blue circles) that are mainly localized in the nucleus and interact directly with at least five HSR modulators (Tables S2A and S2B ). These proteins represent potential HSR modulators with functions in DNA repair, transcriptional regulation, cell-cycle control and protein degradation via the UPS. In conclusion, the regulation of the HSR and thus cell survival during stress relies on a complex cooperation of nuclear processes.
Role of Histone Acetyltransferase EP300 in HSF1 Regulation
The chromatin-modifying histone acetyltransferase complex EP300/CREBBP was identified as a strong positive modulator of the HSR. EP300 downregulation prevented HSF1-dependent HSPA1A transcription ( Figure S2B ), enhanced cytosolic protein aggregation (Figures 2B and S2A) , and reduced cell viability during HS ( Figure S3A ). In contrast, EP300 silencing did not interfere with upregulation of ER chaperones (BiP; Grp94) upon tunicamycin treatment to induce ER stress (data not shown). EP300, besides acetylating histones, also modifies several transcription factors (Caron et al., 2005) and has been reported to bind to heat shock promoter regions (Westerheide et al., 2009 ), suggesting HSF1 as a possible target for acetylation. Strikingly, downregulation of EP300 in HeLa cells reduced the steady-state level of HSF1 by $60% ( Figure 4A ). Note that the detection of HSF1 by immunoblotting was independent of its acetylation status (see legend of Figure 4A ). In contrast, no reduction in HSF1 was observed upon silencing of several other chromatin modifiers that were identified as HSR modulators, including the closely EP300-related histone acetyltransferase CREBBP, the histone demethylase KDM3B, or the nucleosome assembly factor ATRX ( Figure S3B ). EP300 RNAi neither resulted in a significant reduction of HSF1 transcript level nor in a general inhibition of translation ( Figures S3C and S3D) . Furthermore, analysis by flow cytometry showed that EP300 downregulation did not cause cell-cycle arrest (data not shown). Thus, the data suggest that EP300 alters the level of HSF1 by regulating its turnover. EP300 RNAi also reduced the level of HSF1 in HEK293T cells by $40% ( Figure S3E ) and accelerated HSF1 degradation, as observed upon inhibition of translation with cycloheximide (CHX) (Figures 4B and S3F) . Addition of the proteasome inhibitor MG132 largely prevented the degradation of HSF1 ( Figure 4B ), indicating that it occurred via the proteasome. These findings suggested that acetylation by EP300 conformationally stabilizes HSF1, possibly by blocking lysine residues for ubiquitylation.
Trimerization of HSF1 upon HS is considered a prerequisite for chromatin binding (Anckar and Sistonen, 2011) . To test whether EP300 downregulation also affects HSF1 trimerization, we next monitored the formation of HSF1 oligomers by chemical crosslinking with ethylene glycol bis(succinimidylsuccinate) (EGS) (Sarge et al., 1993) . HSF1 complexes migrating at $300 kDa on SDS-PAGE accumulated upon HS and then decayed during recovery during a period of 1-2 hr ( Figure 4C ). HSF1 oligomers still formed when EP300 was downregulated but decayed faster than in control cells ( Figure 4C ), which is consistent with altered conformational properties and reduced activity of HSF1 ( Figure S2B ).
HSF1 Acetylation
To analyze the acetylation status of HSF1, we expressed GFPtagged HSF1 in amino acid isotope-labeled HEK293T cells. HSF1-GFP was immunoprecipitated from normal and EP300 downregulated cells and acetylation of lysine residues analyzed by SILAC (stable isotope labeling by amino acids in cell culture)-based quantitative mass spectrometry (Ong et al., 2002) . Note that endogenous HSF1 could not be analyzed due to its low abundance (Westerheide et al., 2009) . Besides K80 (Westerheide et al., 2009), we identified seven additional lysines of HSF1 to be acetylated, even in the absence of HS, and quantitative data were obtained for K80, K118, K208, K298, and K524 ( Figure 4D ). Acetylation of K118, K208, and K298 was reduced in EP300 downregulated cells by $50 % ( Figure 4D and Table  S3 ). K118 acetylation also showed a tendency to increase with HS. Acetylation of K80 was not reduced upon EP300 silencing ( Figure 4D and Table S3 ).
We next mutated the EP300-dependent acetylation sites to glutamine, mimicking acetylation, or to arginine, maintaining the positive charge, and analyzed the effect of these substitutions on the ability of HSF1 to form nuclear stress bodies (nSB) in response to HS. nSB are initiated through interaction between HSF1 and chromatin at transcription sites of noncoding satellite III RNA (Biamonti and Vourc'h, 2010) and can be used as a proxy for HSF1 functionality (Westerheide et al., 2009 ). EP300 silencing significantly reduced nSB formation by endogenous HSF1, but not by overexpressed HSF1-GFP ( Figure S4A ), which is consistent with a direct role of EP300 in stabilizing the low abundant endogenous HSF1. As previously reported (Westerheide et al., 2009) , mutations K80Q and K80R abrogated nSB formation by HSF1-GFP ( Figures 4E and S4B) . Interestingly, we found that mutation K118Q also abolished nSB formation, whereas K118R formed nSB with similar efficiency to wild-type HSF1-GFP ( Figures 4E and S4B ). Thus, a positively charged residue at position 118 is critical for HSF1 function, and acetylation of K118 by EP300 impairs functionality. In contrast, mutation of K208 and K298 to Q or R had no effect on nSB formation ( Figure 4E ), suggesting that acetylation of these lysines may primarily regulate HSF1 turnover. Indeed, mutations K208Q and K298Q substantially stabilized HSF1-GFP against degradation in HeLa cells, as measured upon addition of CHX (Figure S4C) . Mutation K208R did not stabilize, indicating that the reduced turnover of the K208Q mutant is not due to prevention of ubiquitylation but probably results from the removal of the positive charge. Mutation K118Q, which causes functional inactivation, also did not stabilize ( Figure S4C ).
It has been suggested that the deacetylase SIRT1 prolongs the HSR by deacetylating HSF1 at functionally critical lysines (Raynes et al., 2013; Westerheide et al., 2009 ). Indeed, we found that overexpression of SIRT1 increased the stress-inducible reporter activity in iFluc-Rluc cells by $2-fold ( Figure 4F ). Downregulation of EP300 completely abolished this effect, indicating that EP300 functions upstream of SIRT1. Taken together, these findings support a model in which acetylation by EP300 at K208, K298, and perhaps other lysines conformationally stabilizes HSF1 for activation, whereas increasing acetylation during HS at functionally critical lysines, such as K118, attenuates HSF1. Deacetylation by SIRT1 could oppose this attenuating effect.
Reorganization of the Nuclear Proteome during Heat Stress
The link between EP300 and HSF1 turnover, along with the identification of proteasome subunits as negative HSR modulators, prompted us to explore the role of the proteasome in the HSR in more detail. We first analyzed changes in the nuclear proteome of HeLa cells immediately upon HS (2 hr at 43 C) or after recovery (2 hr at 37 C) by quantitative proteomics using SILAC. Note that the nuclear extracts were essentially free of cytosolic contamination and that both EP300 and HSF1 were mainly localized in the nucleus (Figures S5A and S5B) . We quantified $4,000 proteins, including 36 of the 69 HSR modulators identified above (Figure 2A ) and 212 additional components of the nuclear HSR network (Figure 3) . HS resulted in a significant (A) Decrease in HSF1 level upon silencing of EP300. HeLa cells were treated with control and EP300 esiRNA. After 48 hr, cell extracts were analyzed by SDS-PAGE and immunoblotting with anti-EP300, anti-HSF1, and anti-GAPDH. Detection of HSF1 was independent of acetylation status because the monoclonal anti-HSF1 antibody (ab61382; Abcam) recognizes a peptide comprising residues 378-395. This region contains K391, which was not found to be acetylated (Westerheide et al., 2009 ; this study). HSF1 was quantified by densitometry and was normalized against corresponding GAPDH levels. SDs are from at least three independent experiments. (B) Downregulation of EP300 results in rapid turnover of HSF1 in HEK293T cells. Cycloheximide (CHX; 5 mM) with or without MG132 (5 mM) was added to the cells 48 hr after esiRNA transfection. After 4 hr at 37 C, HSF1 protein level was quantified by immunoblotting. HSF1 in control cells is set to 100%. See also Figure S3F . SDs are from at least three independent experiments. (C) High-molecular-weight oligomer of HSF1 formed during HS is destabilized upon EP300 downregulation. HeLa cells were transfected with either control or EP300 esiRNA. After 48 hr, cells were exposed to HS (2 hr at 43 C), followed by recovery at 37 C for the times indicated. Cell extracts were prepared and subjected to crosslinking with 1 mM EGS (see Extended Experimental Procedures), followed by immunoblotting with anti-HSF1. Crosslinked HSF1 oligomers at $300 kDa (dashed rectangle) (Sarge et al., 1993) were quantified. Amounts present immediately after HS were set to 100%. SDs from at least three independent experiments are shown. (D) HSF1 domain organization indicating the position of acetylated lysines. DBD, DNA-binding domain; HR, heptad repeat; RD, regulatory domain; TAD, transactivation domain. Heat map shows average SILAC ratios of quantified acetylation sites upon EP300 downregulation (48 hr) or upon HS (1 hr at 43 C) relative to control. See Table S3 for details. (E) nSB formation by HSF1-GFP mutants. HeLa cells were transfected with wild-type and mutant HSF1-GFP and exposed to HS (1 hr at 43 C) 24 hr after transfection. The fraction of cells with nSB was quantified. SDs represent results from at least three different fields of view ($100 cells in total). (F) Overexpression of SIRT1 enhances the HSR by an EP300-dependent mechanism. iFluc-Rluc cells were transfected with control esiRNA targeting EGFP or esiRNAs targeting EP300, followed after 24 hr by transfection with Flag-SIRT1 when indicated. 20 hr later, cells were exposed to HS for 2 hr at 43 C followed by 2 hr recovery at 37 C, and reporter activities were measured. SDs are from at least three independent experiments.
See also Figures S3 and S4. accumulation (>1.66-to 17-fold) of a specific set of 32 proteins in the nucleus ( Figure 5A and Table S4A ). Among these proteins are subunits of the 26S proteasome, HSF1, and multiple chaperones and cochaperones ( Figures 5A and 5B) . The chaperones include the stress-inducible Hsp70 (HSPA1A and HSPA6) (Pelham, 1984) and constitutively expressed Hsc70 (HSPA8), as well as numerous Hsp70 cochaperones (BAG5, DNAJA1, DNAJA4, DNAJB1, DNAJB4, DNAJC7, ST13, and STIP1) (Figure 5A and Table S4A ). The accumulation of proteasome subunits and HSF1 in the nucleus was transient and was reversed during recovery, whereas many chaperone components remained elevated (Figure 5A) . Interestingly, 34 proteins increased significantly in the nuclear fraction during recovery ( Figure 5A and Table S4B ), including factors involved in nuclear architecture (LMNB2), transcription (FOSL2 and JUN), RNA transport (NXT1), RNA splicing (SNRPB), and the actin/myosin cytoskeletal machinery.
The chaperones that accumulate in the nucleus upon HS and the proteasome form a network ( Figure S5C ), suggesting a functional cooperation in the clearance of stress-denatured proteins. HSF1  HSPA1A  HSPA8  PSMA1  PSMA2  PSMA3  PSMA6  PSMB1  PSMB3  PSMB4  PSMB5  PSMB6  PSMB7   COIL  CREB1  HSPA1A  JUN   ATRX  BIRC6  CDK9  COIL  DAP3  GTF3C1  GTF3C2  GTF3C3  GTF3C5  HDAC3  HNRNPH2  HNRNPM  KDM3B  MRPS16  RBM14  SKP2  YY1   BIRC6  CALU  CBS  DAP3  DHPS  GTF3C1  GTF3C3  GTF3C5  HNRNPH2  KDM3B  MRPS16  MSH6  NCOR1  PLIN3  PSME1  PTMA  RBM14  SKP2  SMC6  STAT1  UBQLN1 See also Figure S5 and Table S4 .
A B C
Consistent with this interpretation, HS resulted in an $30%-90% depletion of 237 nuclear proteins ( Figure 5C and Table S4C ) without a detectable increase of these proteins in the cytosolic fraction (data not shown). The depleted proteins included 7 HSR modulators and 38 components of the HSR network ( Figure 5D ), as well as many nucleolar and preribosomal proteins (Table S4C) . We confirmed that degradation rather than aggregation was the fate of these proteins; only 37 of them (25 listed in UniProt) were found to aggregate substantially, as indicated by a >1.66-fold increase in the detergent-insoluble fraction of heat-stressed cells (Figure 5C and Table S4D ). However, aggregation of nuclear proteins increased strongly when proteasome function was inhibited during HS by MG132, and multiple proteasomal subunits were recovered in the insoluble fraction ( Figure 5C and Table S4E ).
These results demonstrate that a subset of the nuclear proteome undergoes substantial reorganization during and after HS, with the proteasome system having a critical role in removing damaged proteins.
Role of the Proteasome in Attenuation of the HSR Silencing of individual proteasome components enhanced Fluc reporter activity in iFluc-Rluc cells upon HS in an HSF1-dependent manner ( Figure S6A ). Proteasome activity was inhibited, as judged by the accumulation of GFPu (GFP fused to a constitutive degradation signal), a protein that is normally degraded rapidly via the UPS ( Figure S6B) . Thus, the accumulation of misfolded proteins resulting from proteasome inhibition during HS ( Figure 5C ) might cause the enhancement of the HSR. However, RNAi against proteasome subunits did not increase the peak level of Hsp70 mRNA over that reached during HS alone, but rather delayed its return to control levels by about 4 hr ( Figure 6A ), suggesting a role of the proteasome in attenuating the HSR. Indeed, proteasome inhibition by MG132 delayed the decay of HSF1 oligomers during recovery from HS under conditions in which synthesis of new HSF1 was inhibited by CHX ( Figure 6B ).
To explore a direct role of the proteasome in HSF1 turnover after HS, we performed CHX chase experiments in HeLa cells in the presence and absence of proteasome inhibitors (MG132 or epoxomicin). After HS, degradation of HSF1 was accelerated, particularly in the first hour of recovery, reducing its half-time of decay from $5 hr to $3 hr ( Figure 6C ). HSF1 was stabilized upon proteasome inhibition ( Figure 6C ). Thus, proteasomal degradation of HSF1 occurs with similar kinetics as the decay of Hsp70 mRNA ( Figure 6A ). HS resulted in an upshift of the HSF1 band on SDS-PAGE and immunoblotting ( Figures 6D and S6C) , which is consistent with hyperphosphorylation (Holmberg et al., 2001 ). Treatment of cell extracts with calf intestinal phosphatase resulted in a change in the migration pattern of HSF1 both in the presence and absence of HS ( Figure S6C ), confirming that the slower migrating species of HSF1 represents hyperphosphorylated HSF1. Formation of hyperphosphorylated HSF1 was neither induced nor inhibited by EP300 downregulation (Figure S6D ), suggesting that EP300 maintains HSF1 stability in a phosphorylationindependent manner. During recovery from HS, activated HSF1 did not revert to the less phosphorylated species but was proteasomally degraded, as evident by the stabilization of hyperphosphorylated HSF1 upon proteasome inhibition ( Figures 6D and S6C ). Attempts to demonstrate ubiquitylation of endogenous HSF1 during HS by pull-down with His-tagged ubiquitin were unsuccessful, but when HSF1 was overexpressed, a ladder of polyubiquitylated HSF1 was observed upon proteasome inhibition ( Figure S6E ). The failure to detect ubiquitylation of endogenous HSF1 may be due to the low abundance of HSF1 or to efficient competition for ubiquitin by misfolded proteins. Coupled with the reversibility of ubiquitylation, such competition may ensure that HSF1 remains active until stress-denatured proteins have been cleared by the UPS. . 70 hr after transfection, cells were exposed to HS for 2 hr at 43 C, followed by recovery at 37 C for up to 24 hr. HSPA1A (Hsp70) mRNA was analyzed by RT-PCR and quantified. SDs are from at least three independent experiments. (B) High-molecular-weight oligomer of HSF1 formed during HS is stabilized by proteasome inhibition. HeLa cells were exposed to HS as above and allowed to recover for 2 hr at 37 C. MG132
(5 mM) or DMSO was added together with 2 mM CHX immediately after HS. Cells not exposed to HS with and without MG132 treatment are shown as controls. Cell extracts were analyzed by crosslinking as in Figure 4C . HSF1 oligomers at $300 kDa were quantified with the amount present immediately after HS set to 100%. SDs are from at least three independent experiments. (C) Proteasomal degradation of HSF1 as measured by CHX chase. CHX (5 mM) and 0.1% DMSO or 5 mM MG132 or 10 mM epoxomicin was added to cells immediately after HS. HSF1 protein level was analyzed by immunoblotting and quantified. SDs from at least three independent experiments are shown. y axis in log scale.
(D) Phosphorylated HSF1 generated upon HS is degraded. HSF1 immunoblots from CHX chase experiments as in (C) are shown. See also Figure S6 .
Rebinding of HSF1 to Hsp90 has been suggested to play a role in attenuating the HSR (Bharadwaj et al., 1999; Zou et al., 1998) . We therefore tested whether functional Hsp90 is necessary for the degradation of activated HSF1. Addition of the specific Hsp90 inhibitor 17-AAG (17-N-allylamino-17-demethoxygeldanamycin) immediately after HS had no significant effect on HSF1 turnover (Figure S6F ), although the inhibitor was active ( Figure S6G ). Thus, Hsp90 appears not to be critical for proteasomal degradation of HSF1 after HS.
In summary, during the attenuation phase of the HSR, activated HSF1 undergoes proteasomal degradation in the nucleus. As stress-denatured proteins generally compete with HSF1 for ubiquitylation and proteasomal degradation, the extent of protein damage incurred during stress would control the speed of HSR attenuation.
DISCUSSION
The cytosolic HSR of mammalian cells integrates positive and negative signals from multiple cellular processes and locations, as demonstrated by the RNAi screen reported in this study. Although most of the identified HSR modulators exert their functions in the nucleus, we also detected novel regulatory factors in the cytoplasm, endomembrane system, mitochondria, and the plasma membrane. Future investigations are likely to reveal unanticipated mechanisms by which these factors participate in cell-autonomous and nonautonomous aspects of the HSR.
Role of EP300 in Regulating the HSR Based on our analysis, HSF1 activation upon HS involves the function of multiple chromatin modifiers, centering on the EP300/CREBBP histone acetyltransferase complex. Silencing of EP300 destabilizes HSF1 in nonstressed cells and induces its proteasomal degradation (Figure 7 , steps 1 and 9). As shown by quantitative mass spectrometry, EP300 downregulation results in reduced acetylation of at least three lysines of HSF1 (K118, K208, and K298). Thus, EP300 likely regulates HSF1 directly by acetylation, but effects of EP300 on other factors may also play a role. Acetylation of K118 inhibits chromatin binding of HSF1, i.e., ''deactivating'' acetylation, as reflected in the inability of HSF1 mutant K118Q to form nSB. Acetylation of K80 similarly impairs chromatin binding of HSF1 (Raynes et al., 2013; Westerheide et al., 2009 ; this study), and deacetylation of functionally critical lysines by SIRT1 is suggested to delay HSF1 attenuation (Raynes et al., 2013; Westerheide et al., 2009) . In contrast, we find that acetylation of K208 and K298 does not correlate with functional impairment of HSF1 in nSB formation but rather serves to stabilize HSF1 against degradation, i.e., ''stabilizing'' acetylation. While acetylation of a lysine residue prevents ubiquitylation, it may also modulate protein stability structurally by removing charge repulsion effects (Caron et al., 2005) . Our data suggest that the latter mechanism predominates for K208 acetylation, as only mutation K208Q, but not K208R, resulted in stabilization, although both modifications prevent ubiquitylation. Consistent with a role in attenuation of the HSR, acetylation of K118 (as tested with mutation K118Q) does not result in HSF1 stabilization.
Based on these findings, we suggest a model in which increasing acetylation of HSF1 by EP300 functions as a timing mechanism regulating activation and attenuation of the HSR (Figure 7) . Initial acetylation at K208, K298, and perhaps additional lysines stabilizes HSF1 against proteasomal degradation in the absence of stress and, together with other modifications, renders it competent for DNA binding (Figure 7, step 1 and 2) . The extent of acetylation may increase during HS as both HSF1 and EP300 bind to chromatin at heat shock elements (Westerheide et al., 2009) . Eventually, acetylation of functionally critical lysines such as K118 limits DNA binding capacity and initiates attenuation (Figure 7 , steps 3 and 5). SIRT1 acts downstream of EP300 to remove deactivating acetylation, thereby delaying attenuation (Figure 7 , steps 4 and 6), whereas other deacetylases may remove stabilizing acetylation to accelerate attenuation (Figure 7 , step 7). Fine-tuning of the HSR may be facilitated by the oligomeric nature of active HSF1, with acetylation and deacetylation occurring on different subunits. Interestingly, a similar mechanism appears to operate in the regulation of the transcription In the absence of stress, HSF1 is maintained in an inactive state by chaperones Hsp70 and Hsp90. This HSF1 is mainly localized in the nucleus. HS and other forms of protein conformational stress lead to accumulation of misfolded proteins, which displace HSF1 from Hsp70/Hsp90. HSF1 oligomerizes, undergoes posttranslational modifications by phosphorylation and acetylation, and triggers the HSR. Increasing acetylation of HSF1 by EP300 functions as a timer for the induction and attenuation of the HSR in cooperation with the deacetylase SIRT1 (and possibly other deacetylases). EP300 downregulation results in destabilization of HSF1 and premature degradation by the proteasome. Activated HSF1 is normally degraded by the proteasome during the attenuation phase of the HSR. Ac, acetylation; P, phosphorylation; and Ub, ubiquitin. See Discussion for details of the proposed model. factor HIF1a. Upon acetylation by EP300, HIF1a is stabilized against proteasomal degradation (Geng et al., 2012) , whereas hyperacetylation upon silencing of SIRT1 has been shown to reduce HIF1a transcriptional activity (Laemmle et al., 2012) .
Attenuation of the HSR by the Proteasome
Rebinding to chaperones is thought to mediate inactivation of HSF1 as chaperone capacity is restored during recovery from stress (Zou et al., 1998) (Figure 7, step 8) . Our observation that activated (i.e., hyperphosphorylated) HSF1 is degraded by the proteasome suggests an alternative (or parallel) mechanism for attenuation of the HSR (Figure 7, step 7 ). An important element of this mechanism is the coupling of HSR attenuation with clearance of misfolded proteins by the proteasome. The nuclear proteome is sensitive to different forms of stress (Boulon et al., 2010) . We find that many nuclear proteins are damaged during HS and must be degraded in a proteasome-dependent manner, explaining the transient accumulation of proteasome and chaperone components in the nucleus upon HS. The misfolded proteins generated during stress would compete with HSF1 for ubiquitylation and proteasomal degradation, thereby delaying attenuation of the HSR until clearance of damaged proteins has been accomplished. Thus, attenuation of the stress response is directly linked with recovery of proteome balance.
It may be inferred from these considerations that the increase of protein misfolding associated with cellular aging and neurodegenerative diseases would result in chronic stress and deregulation of the HSR by overwhelming proteasome capacity.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection HeLa and HEK293T cells were cultured under standard conditions (see Extended Experimental Procedures). Transfection was performed with Lipofectamine and PLUS reagent (Invitrogen). esiRNA reverse-transfection experiments were performed with Lipofectamine RNAiMAX (Invitrogen). The stable reporter cell line expressing Fluc and Rluc (iFluc-Rluc) used in the screen and the reporter cell line stably expressing FlucDM-GFP (Gupta et al., 2011) were generated by standard methods.
Genome-Scale RNA Interference Screen The esiRNA library was designed and synthesized as described (Kittler et al., 2005 (Kittler et al., , 2007 . Screen experiments were performed in 384 well format using a robotics system. Dual-Glo luciferase reagent (Promega) was used to measure Fluc and Rluc activities. A detailed screening protocol and the analysis of screen results are described in the Extended Experimental Procedures.
Fluorescence Microscopy
Fluorescence imaging was performed on a Zeiss Axiovert 200M fluorescence microscope equipped with a Zeiss Axiocam HRM camera and images analyzed using Axiovision Rel 4.7 software.
SILAC Labeling and Liquid Chromatography-Tandem Mass Spectrometry Analysis SILAC labeling of HeLa and HEK293T cells was performed in custom medium supplemented with light, medium, or heavy arginine and lysine isotopes (see the Extended Experimental Procedures).
Nuclear fractions were prepared using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific). To prepare detergent insoluble fractions containing aggregated proteins, cells were lysed in RIPA lysis buffer, cell lysates were centrifuged (30 min at 14,000 3 g), and pellets were dissolved in SDS lysis buffer. Sample preparation for liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described in detail in the Extended Experimental Procedures. Protein identification and SILAC based quantitation was performed using MaxQuant (version 1.1.1.36).
Miscellaneous Methods
Flow cytometry, immunoblotting and antibodies used (Table S5) , RT assays and the PCR primers used (Table S6) , radiolabeling of cells, chemical crosslinking of HSF1, and computational and bioinformatic data analysis are described in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
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